Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicolò Bisceglia
Observed names:
Nicolo Bisceglia,
Nicolo' Bisceglia
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
ORCID:
0009-0004-3202-3300
Observed ORCID:
0009-0004-3202-3300
OpenAlex ID:
A5007408460
Trabecular bone score as a possible new surgical recommendation in patients with asymptomatic primary hyperparathyroidism
2025
·
Nicolò Bisceglia
, Matteo Malagrinò
, et al.
·
Journal of Endocrinological Investigation
·
7
PDF
Dietary calcium intake in primary hyperparathyroidism and in its normocalcemic variant: a case-control study
2025
·
Nicolò Bisceglia
, Matteo Malagrinò
, et al.
·
Frontiers in Endocrinology
·
3
PDF
Case Report: Reopening the anabolic window — romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients
2026
·
Simona Barbuto
, Paolo Mastromauro
, et al.
·
Frontiers in Endocrinology
·
1
PDF
Elevated FGF23 Despite Biochemical Control Reveals Hidden Mineral Dysregulation in Chronic Hypoparathyroidism
2025
·
Matteo Malagrinò
, Anna Piazza
, et al.
·
Journal of the Endocrine Society
·
1
PDF
L’osteoporosi nel paziente con malattia renale cronica: strategie di gestione
2026
·
Nicolò Bisceglia
, Guido Zavatta
, et al.
·
L Endocrinologo
P104 - ECE_3612 - Effect of antiresorptive therapy on post-parathyroidectomy bone mass gain in primary hyperparathyroidism: a pilot study
2026
·
Nicolò Bisceglia
, Anna Piazza
, et al.
·
European Journal of Endocrinology
P80 - ECE_3377 - Phenotyping hypercalciuria in primary hyperparathyroidism before and after parathyroidectomy: a large single-center study
2026
·
Sara Capra
, Nicolò Bisceglia
, et al.
·
European Journal of Endocrinology
Treatment With Romosozumab In Progressive Pseudorheumatoid Dysplasia
2025
·
Nicolò Bisceglia
, Emanuela Scarano
, et al.
·
JCEM Case Reports
PDF
FGF23 in chronic hypoparathyroidism: clinical implications of phosphate regulation
2025
·
Anna Piazza
, Matteo Malagrino'
, et al.
·
Endocrine Abstracts
Time to severe chronic kidney disease and nephrolithiasis in hypoparathyroidism: results from a large longitudinal retrospective study
2024
·
Anna Piazza
, Nicolo Bisceglia
, et al.
·
Endocrine Abstracts
Elevated serum uric acid in asymptomatic primary hyperparathyroidism: a biomarker of disease severity?
2024
·
Matteo Malagrino
, Nicolo Bisceglia
, et al.
·
Endocrine Abstracts
Low trabecular bone score better predicts prevalent vertebral fractures in younger rather than older women starting endocrine therapy for breast cancer
2023
·
Matteo Malagrino
, Anna Piazza
, et al.
·
Endocrine Abstracts
Trabecular bone score increases the proportion of patients with asymptomatic primary hyperparathyroidism meeting surgical criteria
2023
·
Matteo Malagrino
, Anna Piazza
, et al.
·
Endocrine Abstracts
Show more works
View as search
Works count:
13
Citation count:
12
H-index:
2
I10-index:
Year
Topic
Type